WHO ICTRP trial
Efficacy and safety of original and generic sugammadex for postoperative…
ChiCTR2400086021 · Chinese Clinical Trial Registry (ChiCTR) · Not Recruiting
Key facts
| Trial ID | ChiCTR2400086021 |
|---|---|
| Public title | Efficacy and safety of original and generic sugammadex for postoperative residual neuromuscular blockade in children: a double-blind randomised controlled non-inferiority trial |
| Scientific title | Efficacy and safety of original and generic sugammadex for postoperative residual neuromuscular blockade in children: a double-blind randomised controlled non-inferiority trial |
| Primary sponsor | Shanghai Children's Medical Center, Shanghai Jiaotong University School of Medicine |
| Registry | Chinese Clinical Trial Registry (ChiCTR) |
| Recruitment status | Not Recruiting |
| Study type | Interventional study |
| Phase | 4 |
| Countries | China |
| Conditions | Obstructive sleep apnea syndrome |
| Interventions | original sugammadex group:use of original sugammadex for postoperative residual neuromuscular blockade;generic sugammadex group :use of generic sugammadex for postoperative residual neuromuscular blockade |
| Registration date | Jun 24, 2024 |
| Target size | original sugammadex group:58;generic sugammadex group :58 |
| Registry page | chictr.org.cn |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: